Literature DB >> 22131596

Every cloud has a silver lining--treatment of complicated breathing patterns during sleep.

Winfried J Randerath1.   

Abstract

Mesh：

Year:  2011        PMID： 22131596      PMCID： PMC3208836          DOI： 10.5665/sleep.1416

Source DB:  PubMed          Journal:  Sleep        ISSN： 0161-8105            Impact factor:   5.849


× No keyword cloud information.
  12 in total

1.  Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period.

Authors:  C Philippe; M Stoïca-Herman; X Drouot; B Raffestin; P Escourrou; L Hittinger; P-L Michel; S Rouault; M-P d'Ortho
Journal:  Heart       Date:  2005-06-17       Impact factor: 5.994

2.  Beneficial effects of adaptive servo ventilation in patients with chronic heart failure.

Authors:  Takashi Koyama; Hiroyuki Watanabe; Yusuke Kobukai; Shin Makabe; Yoshiko Munehisa; Kenji Iino; Toshimitsu Kosaka; Hiroshi Ito
Journal:  Circ J       Date:  2010-07-29       Impact factor: 2.993

3.  Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure.

Authors:  H Teschler; J Döhring; Y M Wang; M Berthon-Jones
Journal:  Am J Respir Crit Care Med       Date:  2001-08-15       Impact factor: 21.405

4.  Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure.

Authors:  Thomas Bitter; Nina Westerheide; Christian Prinz; Mohamed Sajid Hossain; Jürgen Vogt; Christoph Langer; Dieter Horstkotte; Olaf Oldenburg
Journal:  Eur Heart J       Date:  2010-09-16       Impact factor: 29.983

5.  Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration.

Authors:  Takatoshi Kasai; Yasuhiro Usui; Toru Yoshioka; Naotake Yanagisawa; Yoshifumi Takata; Koji Narui; Tetsu Yamaguchi; Akira Yamashina; Shin-ich Momomura
Journal:  Circ Heart Fail       Date:  2009-11-20       Impact factor: 8.790

6.  Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP).

Authors:  Michael Arzt; John S Floras; Alexander G Logan; R John Kimoff; Frederic Series; Debra Morrison; Kathleen Ferguson; Israel Belenkie; Michael Pfeifer; John Fleetham; Patrick Hanly; Mark Smilovitch; Clodagh Ryan; George Tomlinson; T Douglas Bradley
Journal:  Circulation       Date:  2007-06-11       Impact factor: 29.690

7.  A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure.

Authors:  Justin C T Pepperell; Nick A Maskell; David R Jones; Beverley A Langford-Wiley; Nicky Crosthwaite; John R Stradling; Robert J O Davies
Journal:  Am J Respir Crit Care Med       Date:  2003-08-19       Impact factor: 21.405

8.  Adaptive servo-ventilation in patients with coexisting obstructive sleep apnoea/hypopnoea and Cheyne-Stokes respiration.

Authors:  Winfried J Randerath; Wolfgang Galetke; Sven Stieglitz; Cordula Laumanns; Thorsten Schäfer
Journal:  Sleep Med       Date:  2008-07-21       Impact factor: 3.492

9.  Adaptive servoventilation versus noninvasive positive pressure ventilation for central, mixed, and complex sleep apnea syndromes.

Authors:  Timothy I Morgenthaler; Peter C Gay; Nancy Gordon; Lee K Brown
Journal:  Sleep       Date:  2007-04       Impact factor: 5.849

10.  Combined adaptive servo-ventilation and automatic positive airway pressure (anticyclic modulated ventilation) in co-existing obstructive and central sleep apnea syndrome and periodic breathing.

Authors:  Winfried J Randerath; Wolfgang Galetke; Marlene Kenter; Kerstin Richter; Thorsten Schäfer
Journal:  Sleep Med       Date:  2009-03-20       Impact factor: 3.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.